Has anyone been able to find the scientific paper this was published in or is purely hype from the company?
I am a little sceptical as it is hard to get antibodies to cross the blood-brain barrier and even harder to get them inside the cell. Of course there is the other issue that it is all pre-clinical.
Ann: PAT-DX1 Crosses Blood Brain Barrier to Reduce Tumour Size, page-68
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.001(100%) |
Mkt cap ! $4.731M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $2.65K | 1.540M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 52 | 132475723 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 53784442 | 24 |
View Market Depth
| Last trade - 16.10pm 22/07/2025 (20 minute delay) ? |
| PAB (ASX) Chart |